ID

33521

Descripción

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Palabras clave

Versiones (4)

1. 11/12/18 11/12/18 -
2. 6/6/19 6/6/19 -
3. 12/6/19 12/6/19 -
4. 27/9/21 27/9/21 -

Titular de derechos de autor

GSK group of companies

Subido en

11 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia